Intra-Arterial Cis-Diamminedichloroplatinum-II in Pediatric Osteosarcoma: Relationship of Effect on Primary Tumor to Survival
Authors:
- 1 January 1988
- book chapter
- Published by Springer Nature
- p. 275-282
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III.Journal of Clinical Oncology, 1987
- Results of treatment of stage 3A Hodgkin's diseaseCancer, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.Journal of Clinical Oncology, 1985
- Chemotherapy in Osteosarcoma: Advances and Controversies1985
- Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studiesCancer, 1983
- Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyCancer, 1982
- Multidrug chemotherapy in pulmonary treatment of osteosarcomaJournal of Bone and Joint Surgery, 1976
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958